January 16, 2025

When hiring C-suite executives, organisations face a critical decision: should they prioritise youthful dynamism or seasoned expertise? This debate is particularly relevant to the generics and biosimilars industry, where success hinges on balancing innovation and regulatory compliance. A younger executive might bring fresh ideas and a tech-savvy approach, while an experienced leader offers stability and